Kari Stefansson
Professor
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (9)
Obstructive sleep apnea (OSA) is a common, heritable disorder with diverse clinical presentations and etiologies. We conducted a genome-wide association meta-analysis of 492,107 individuals, including 46,028 OSA cases, identifying 14 genome-wide significant loci, eight of which are novel. Analyses adjusting for body mass index (BMI) revealed three loci independent of obesity, implicating alternative biological pathways contributing to disease. Integrative functional analyses, including chromatin interaction mapping, fine-mapping, and eQTL colocalization, prioritized candidate effector genes. Notably, implicated genes in chondrocytes were associated with craniofacial morphology in both mouse and human multivariate genotype-phenotype mapping, supporting a role for craniofacial structure in OSA risk. These findings highlight key genetic pathways (obesity-related, neurological, and craniofacial) underlying the development of OSA, offering new insights into its complex etiology.
Year:
2026
The North Sea’s historical migrations have impacted the genetic structure of its neighbouring populations. We analysed haplotype sharing among 858,635 modern individuals from Denmark and Britain to infer migration history from the Middle Ages to the modern day. We estimated the genetic relationship among 370,259 Danes using Danish healthcare registries and validated those with retrievable pedigree relationships from a national family registry. We also compared their haplotype sharing with 488,376 British individuals from the UK Biobank. Our analysis revealed the fine-grained population genetic history of Denmark and identified distinct coastal and island communities with a history of genetic isolation and bottlenecks. We observed a significant population decline in Jutland compared to Zealand from the late medieval period to the start of early modern period, accompanied by migration from Jutland to Zealand, corresponding to historical evidence. We identified two major haplotype sharing patterns between Denmark and Great Britain: (1) early coast-to-coast connections between South Jutland and eastern England, likely driven by migration, settlement, continuous trade and the movement of people across the North Sea from the Middle Ages through early modern times, and (2) later city-to-city connections such as those between London and København, likely shaped by the reorientation of economic and trading centres in Britain and Denmark, and the increased shipping from early modern times towards the Industrial Revolution. Further comparisons using other North Sea countries showed both shared and unique histories of genetic exchange with Denmark and Britain. Our study provides novel genetic evidence of migration across the North Sea from the Middle Ages to the Industrial Revolution. It highlights the power of nationwide biobanks in reconstructing fine-scale historical population movements among closely related populations.
Year:
2025
Psychiatric disorders display high levels of comorbidity and genetic overlap 1,2 . Genomic methods have shown that even for schizophrenia and bipolar disorder, two disorders long-thought to be etiologically distinct 3 , the majority of genetic signal is shared 4 . Furthermore, recent cross-disorder analyses have uncovered over a hundred pleiotropic loci shared across eight disorders 5 . However, the full scope of shared and disorder-specific genetic basis of psychopathology remains largely uncharted. Here, we address this gap by triangulating across a suite of cutting-edge statistical genetic and functional genomic analyses applied to 14 childhood- and adult-onset psychiatric disorders (1,056,201 cases). Our analyses identify and characterize five underlying genomic factors 6 that explain the majority of the genetic variance of the individual disorders (∼66% on average) and are associated with 268 pleiotropic loci. We observed particularly high levels of polygenic overlap 7 and local genetic correlation 8 and very few disorder-specific loci 9 for two factors defined by: ( i ) schizophrenia and bipolar disorder (“SB factor”), and by ( ii ) major depression, PTSD, and anxiety (“internalizing factor”). At the functional level, we applied multiple methods 10–12 which demonstrated that the shared genetic signal across the SB factor was substantially enriched in genes expressed in excitatory neurons, whereas the internalizing factor was associated with oligodendrocyte biology. By comparison, the genetic signal shared across all 14 disorders was enriched for broad biological processes (e.g., transcriptional regulation). These results indicate increasing differentiation of biological function at different levels of shared cross-disorder risk, from quite general vulnerability to more specific pathways associated with subsets of disorders. These observations may inform a more neurobiologically valid psychiatric nosology and implicate novel targets for therapeutic developments designed to treat commonly occurring comorbid presentations.
Year:
2025
Antidepressants exhibit a considerable variation in efficacy, and increasing evidence suggests that individual genetics contribute to antidepressant treatment response. Here, we combined data on antidepressant non-response measured using rating scales for depressive symptoms, questionnaires of treatment effect, and data from electronic health records, to increase statistical power to detect genomic loci associated with non-response to antidepressants in a total sample of 135,471 individuals prescribed antidepressants (25,255 non-responders and 110,216 responders). We performed genome-wide association meta-analyses, genetic correlation analyses, leave-one-out polygenic prediction, and bioinformatics analyses for genetically informed drug prioritization. We identified two novel loci (rs1106260 and rs60847828) associated with non-response to antidepressants and showed significant polygenic prediction in independent samples. Genetic correlation analyses show positive associations between non-response to antidepressants and most psychiatric traits, and negative associations with cognitive traits and subjective well-being. In addition, we investigated drugs that target proteins likely involved in mechanisms underlying antidepressant non-response, and shortlisted drugs that warrant further replication and validation of their potential to reduce depressive symptoms in individuals who do not respond to first-line antidepressant medications. These results suggest that meta-analyses of GWAS utilizing real-world measures of treatment outcomes can increase sample sizes to improve the discovery of variants associated with non-response to antidepressants.
Year:
2024
Mutations that affect RNA splicing significantly impact human diversity and disease. Here we present a method using transformers, a type of machine learning model, to detect splicing from raw 45,000-nucleotide sequences. We generate embeddings with residual neural networks and apply hard attention to select splice site candidates, enabling efficient training on long sequences. Our method surpasses the leading tool, SpliceAI, in detecting splice sites in GENCODE and ENSEMBL annotations. Using extensive RNA sequencing data from an Icelandic cohort of 17,848 individuals and the Genotype-Tissue Expression (GTEx) project, our method demonstrates superior performance in detecting splice junctions compared to SpliceAI-10k (PR-AUC = 0.834 vs. PR-AUC = 0.820) and is more effective at identifying disease-related splice variants in ClinVar (PR-AUC = 0.997 vs. PR-AUC = 0.996). These advancements hold promise for improving genetic research and clinical diagnostics, potentially leading to better understanding and treatment of splicing-related diseases.
Year:
2024
Mendelian Randomization studies indicate that BMI contributes to various diseases, but it’s unclear if this is entirely mediated by BMI itself. This study examines whether disease risk from BMI-associated sequence variants is mediated through BMI or other mechanisms, using data from Iceland and the UK Biobank. The associations of BMI genetic risk score with diseases like fatty liver disease, knee replacement, and glucose intolerance were fully attenuated when conditioned on BMI, and largely for type 2 diabetes, heart failure, myocardial infarction, atrial fibrillation, and hip replacement. Similar attenuation was observed for chronic kidney disease and stroke, though results varied. Findings were consistent across sexes, except for myocardial infarction. Residual effects may result from temporal BMI changes, pleiotropy, measurement error, non-linear relationships, non-collapsibility, or confounding. The attenuation extent of BMI genetic risk score on disease associations suggests the potential impact of reducing BMI on disease risk.
Year:
2024
Gene promoter and enhancer sequences are bound by transcription factors and are depleted of methylated CpG sites (cytosines preceding guanines in DNA). The absence of methylated CpGs in these sequences typically correlates with increased gene expression, indicating a regulatory role for methylation. We used nanopore sequencing to determine haplotype-specific methylation rates of 15.3 million CpG units in 7,179 whole-blood genomes. We identified 189,178 methylation depleted sequences where three or more proximal CpGs were unmethylated on at least one haplotype. A total of 77,789 methylation depleted sequences (~41%) associated with 80,503 cis -acting sequence variants, which we termed allele-specific methylation quantitative trait loci (ASM-QTLs). RNA sequencing of 896 samples from the same blood draws used to perform nanopore sequencing showed that the ASM-QTL, that is, DNA sequence variability, drives most of the correlation found between gene expression and CpG methylation. ASM-QTLs were enriched 40.2-fold (95% confidence interval 32.2, 49.9) among sequence variants associating with hematological traits, demonstrating that ASM-QTLs are important functional units in the noncoding genome.
Year:
2024
Two-thirds of all human conceptions are lost, in most cases before clinical detection. The lack of detailed understanding of the causes of pregnancy losses constrains focused counseling for future pregnancies. We have previously shown that a missense variant in synaptonemal complex central element protein 2 ( SYCE2 ), in a key residue for the assembly of the synaptonemal complex backbone, associates with recombination traits. Here we show that it also increases risk of pregnancy loss in a genome-wide association analysis on 114,761 women with reported pregnancy loss. We further show that the variant associates with more random placement of crossovers and lower recombination rate in longer chromosomes but higher in the shorter ones. These results support the hypothesis that some pregnancy losses are due to failures in recombination. They further demonstrate that variants with a substantial effect on the quality of recombination can be maintained in the population.
Year:
2024
This study aimed to uncover novel genes associated with neurodevelopmental disorders (NDD) by leveraging recent large-scale de novo burden analysis studies to enhance a virtual gene panel used in a diagnostic setting. We re-analyzed historical trio-exome sequencing data from 745 individuals with NDD according to the most recent diagnostic standards, resulting in a cohort of 567 unsolved individuals. Next, we designed a virtual gene panel containing candidate genes from three large de novo burden analysis studies in NDD and prioritized candidate genes by stringent filtering for ultra-rare de novo variants with high pathogenicity scores. Our analysis revealed an increased burden of de novo variants in our selected candidate genes within the unsolved NDD cohort and identified qualifying de novo variants in seven candidate genes: RIF1, CAMK2D, RAB11FIP4, AGO3, PCBP2, LEO1 , and VCP . Clinical data were collected from six new individuals with de novo or inherited LEO1 variants and three new individuals with de novo PCBP2 variants. Our findings confirm LEO1 as a risk gene for autism and intellectual disability. Furthermore, we prioritize PCBP2 as a candidate gene for NDD associated with motor and language delay. In summary, by leveraging de novo burden analysis studies, employing a stringent variant filtering pipeline, and engaging in targeted patient recruitment, our study contributes to the identification of novel genes implicated in NDDs.
Year:
2024
Collaborators (71)
Frank Kooy
Professor
University of Antwerp
Jordan Smoller
Professor
Massachusetts General Hospital
Diego R. Mazzotti, Ph.D.
Associate Professor, Medical Informatics
University of Kansas Medical Center
Peter A Cistulli
Professor of Sleep Medicine
University of Sydney
Soriul Kim
Assistant Professor
Korea University College of Medicine and School of Medicine
Naomi Wray
University of Queensland
Laura Rasmussen-Torvik
Professor and Division Chief, Epidemiology
Northwestern University Feinberg School of Medicine
Thorhildur Ólafsdóttir
University of Iceland
Hafsteinn Einarsson
Head of the Faculty of Industrial Engineering, Mechanical Engineering and Computer Science
University of Iceland
Søren Brunak
Professor of Disease Systems Biology, Research Director
Københavns Universitet
Stephen V Faraone
Distinguished Professor
SUNY Upstate Medical University
Gerome Breen
Professor of Psychiatric Genetics
King’s College London
G. Bragi Walters
Research Assistant Professor
University of Iceland
Howard Edenberg
Distinguished Professor
Indiana University School of Medicine
Karina Banasik
Associate Professor
Technical University of Denmark
Christina Mikkelsen
-
Susan Santangelo
Research Professor
Tufts University School of Medicine
Ditte Demontis
Aarhus University
Na Cai
Assistant Professor
ETH Zürich
Sisse Rye Ostrowski
Københavns Universitet
Caroline Nievergelt
Professor
University of California, San Diego
James Knowles
Distinguished Professor and Executive Director of the HGINJ
Rutgers University - Busch Campus
Laufey Tryggvadottir
Professor
University of Iceland
Joanna Biernacka
Associate Professor
Mayo Clinic
Andrew Grotzinger
Associate Professor
Memorial University of Newfoundland
Benjamin Neale
Associate Professor
Broad Institute
Kenneth S. Kendler
Professor
Virginia Commonwealth University
Brittany Mitchell
Senior Research Fellow
QIMR Berghofer Medical Research Institute
David Westergaard
Associate Professor
Technical University of Denmark
John Hettema
Professor
Texas A&M University
Sara Hägg
Senior Researcher
Karolinska Institutet
Phil Lee
Associate Professor
Massachusetts General Hospital
Oleksandr Frei
Associate Professor (20%)
University of Oslo
Sandra Sanchez-Roige
Associate Professor
University of California, San Diego
Murray Stein
Distinguished Professor
University of California, San Diego
Michael Zuscik
Mack Clayton Professor, Vice Chair of Research, Director of the Colorado Program for Musculoskeletal Research
University of Colorado Anschutz Medical Campus
Laura Thornton
Research Professor
University of North Carolina
Miguel E. Rentería
Group Leader, Computational Neurogenomics Lab
QIMR Berghofer Medical Research Institute
Laust Hvas Mortensen
Professor
University of Copenhagen
H S Nielsen
Professor
Copenhagen University Hospital
Sarah Medland
QIMR Berghofer Medical Research Institute
Christian Erikstrup
Chair Professor
Aarhus University
Joel Gelernter
Professor
Yale University School of Medicine
Mette Nyegaard
Head of Department
Aalborg University
Edoardo Errichiello
Assistant Professor
University of Pavia
Manuel Mattheisen
Associate Professor
Ludwig-Maximilians-Universität München
Barbara Franke
Head of department
Radboud University Medical Center
Michael Gandal
William & Noreen Hetznecker Associate Professor
University of Pennsylvania
Ásgeir Haraldsson
-
Nicholas Martin
Senior Scientist and Senior Principal Research Fellow
QIMR Berghofer Medical Research Institute
Lili Milani
Professor & Head of Estonian Biobank
University of Tartu
Josefin Werme
University of Amsterdam
Thomas Folkmann Hansen
Professor
Technical University of Denmark
Runolfur Palsson
Professor of Medicine (Kidney Diseases)
University of Iceland
Karen Mitchell
Assistant Professor
Boston University
Anne Justice
Associate Professor
Geisinger Health
Elliot M. Tucker-Drob
Faculty Research Associate
University of Texas at Austin
Ole A. Andreassen
Oslo University Hospital
Ole Birger Pedersen
Professor
Zealand University Hospital
Irwin Waldman
Professor
Emory University
Brandon Coombes
Assistant Professor of Biostatistics
Mayo Clinic
Timothy Morgenthaler
Professor of Medicine
Mayo Clinic
Chol Shin
Seoul National University Hospital
Wouter Peyrot
VU medisch centrum
Sigrún Helga Lund
Professor
University of Iceland
Katherine Jonas
Assistant Professor
Stony Brook University
Bhajan Singh
University of Western Australia
Aylwyn Scally
Group leader
University of Cambridge
Eva Hoffmann
Professor
Københavns Universitet
Yi Lu
Karolinska Institutet
John Nurnberger
Professor/Distinguished Professor
Indiana University School of Medicine
Make your next move.
Prepare your application
Review drafts before you send them.